Fulgent Genetics, Inc. (FLGT) Tops Q1 EPS by $1.66, Lowers FY22 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts FLGT Hot Sheet
Join SI Premium – FREE
Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q1 EPS of $5.08, $1.66 better than the analyst estimate of $3.42. Revenue for the quarter came in at $320.3 million versus the consensus estimate of $244.65 million.
GUIDANCE:
Fulgent Genetics, Inc. sees FY2022 EPS of $6.00, versus the consensus of $7.00. Fulgent Genetics, Inc. sees FY2022 revenue of $660 million, versus the consensus of $650 million.
For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Robinhood (HOOD) Tops Q3 EPS by 5c, Misses on Revenue
- DMC Global (BOOM) Tops Q3 EPS by 37c; Offers Guidance
- W. P. Carey (WPC) Misses Q3 EPS by 8c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
